Boussamet, L., Montassier, E., Soulillou, J., & Berthelot, L. (2022). Anti α1-3Gal antibodies and Gal content in gut microbiota in immune disorders and multiple sclerosis. Clinical immunology (Orlando, Fla.), 235, 108693. https://doi.org/10.1016/j.clim.2021.108693
Style de citation ChicagoBoussamet, Léo, Emmanuel Montassier, Jean-Paul Soulillou, et Laureline Berthelot. "Anti α1-3Gal Antibodies and Gal Content in Gut Microbiota in Immune Disorders and Multiple Sclerosis." Clinical Immunology (Orlando, Fla.) 235 (2022): 108693. https://dx.doi.org/10.1016/j.clim.2021.108693.
Style de citation MLABoussamet, Léo, et al. "Anti α1-3Gal Antibodies and Gal Content in Gut Microbiota in Immune Disorders and Multiple Sclerosis." Clinical Immunology (Orlando, Fla.), vol. 235, 2022, p. 108693.